Drug-Development Challenges for Small Biopharmaceutical Companies

Small biopharmaceutical companies encounter challenges in designing and implementing clinical development programs. This article discusses the approaches these companies take toward addressing such obstacles. Small biopharmaceutical companies are becoming increasingly important as drivers of innovat...

Ausführliche Beschreibung